Simard John's Form 4 filing
XBiotech Inc. (XBIT) · filed Oct 6, 2021
- Accession no.
- 0001209191-21-059849
- Filed
- Oct 6, 2021
- Trade date
- Oct 4-6, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $624.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Simard JohnCIK 0001639078 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2021 | Common Stock | SSaleDisposed | −23,681 | $13.08 | −$309,747.48 | 3,987,384 | Direct | |
| Oct 5, 2021 | Common Stock | SSaleDisposed | −14,218 | $12.66 | −$179,999.88 | 3,973,166 | Direct | |
| Oct 6, 2021 | Common Stock | SSaleDisposed | −10,714 | $12.53 | −$134,246.42 | 3,962,452 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.